Vinorelbine: Cell cycle kinetics and differential sensitivity of human lymphocyte subpopulations

Toxicology Letters

Volumn 93, Issue 2-3, 1997, Pages 171-176

  González Cid, Marcela ^a   Larripa, Irene ^a   Slavutsky, Irma ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

Cell proliferation; Human lymphocytes; MAC (morphology antibody chromosome) method; Spindle poisons; Vinorelbine (VRB)

Indexed keywords

NAVELBINE; VINCA ALKALOID;

ARTICLE; BLOOD; CELL CYCLE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; HUMAN CELL; HUMAN EXPERIMENT; KINETICS; LYMPHOCYTE SUBPOPULATION; MALE; MITOSIS; MITOSIS INDEX; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; FEMALE; HUMANS; LYMPHOCYTE SUBSETS; MALE; METAPHASE; MIDDLE AGED; MITOTIC INDEX; VINBLASTINE;

MYCOBACTERIUM AVIUM COMPLEX (MAC); VINCA;

EID: 0344404224     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(97)00089-1     Document Type: Article

References (25)

1. Potier P. The synthesis of Navelbine® prototype of a new series of vinblastine derivatives. Semin. Oncol. 16:1989;2-4.
2. Krikorian A., Rahmani R., Bromet M., Bore P., Cano J.P. Pharmacokinetics and metabolism of Navelbine® Semin. Oncol. 16:1989;21-25.
3. Boiron M., Niitani H., Queisser W. Navelbine®. Introduction. Semin. Oncol. 16:1989;1.
4. Cros S., Wright M., Morimoto M., Lataste H., Couzinier J.P., Krikorian A. Experimental antitumor activity of Navelbine® Semin. Oncol. 16:1989;15-20.
5. Burris H.A., Fields S. Summary of data from in vitro and phase I Vinorelbine (Navelbine) studies. Semin. Oncol. 21:1994;14-20.
6. Besenval M., Delgado M., Demarez J.P., Krikorian A. Safety and tolerance of Navelbine® in phase I-II clinical studies. Semin. Oncol. 16:1989;37-40.
7. Teerenhovi L., Wasenius V.M., Franssila K., Keinanen M., Knuutila S. A method for analysis of cell morphology, banded karyotype, and immunoperoxidase identification of lymphocyte subset on the same cell. Am. J. Clin. Pathol. 85:1986;602-604.
8. Slavutsky I., Knuutila S. Micronucleous formation in different lymphocyte subpopulations in peplomycin-treated and control cultures. Mutat. Res. 219:1989;257-261.
9. Pauwels O., Kiss R., Pasteels J.L., Atassi G. Cytotoxicity, cell cycle kinetics and morphonuclear-induced effects of Vinca alkaloid anticancer agents. J. Pharm. Pharmacol. 47:1995;870-875.
10. González Cid M., Cuello M.T., Larripa I. Mitotic arrest and anaphase aberrations induced by vinorelbine in hamster cells in vitro. Anti-Cancer Drugs. 8:1997;529-532.
11. Perry P., Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature. 251:1974;156-158.
12. Schneider E.L., Nakanishi Y., Lewis J., Sternberg H. Simultaneous examination of sister chromatid exchanges and cell replication kinetics in tumor and normal cells in vivo. Cancer Res. 41:1981;4973-4975.
13. Miller B.M., Adler I.D. Suspect spindle poisons: analysis of c-mitotic effects in mouse bone. Mutagenesis. 4:1989;208-215.
14. Knuutila S., Nylund S.J., Wessman M., Larramendy M.L. Analysis genotype and phenotype on the same interphase or mitotic cell: A manual of MAC (Morphology Antibody Chromosomes) methodology. Cancer Genet. Cytogenet. 72:1994;1-15.
15. Rainaldi G., Flori L., Colella C.M., Mariani T., Piras A., Simi S., Simili M. Analysis by BrUdR-labelling technique of induced aneuploidy in mammalian cells in culture. Mutat. Res. 177:1987;255-260.
16. Pacchierotti F., Bassani B., Leopardi P., Zijno A. Origin of aneuploidy in relation to disturbances of cell-cycle progression. II: Cytogenetic analysis of various parameters in mouse bone marrow cells after colchicine or hydroquinone treatment. Mutagenesis. 6:1991;307-311.
17. Hsu T.C., Liang J.C., Shirley L.R. Aneuploidy induction by mitotic arrestants. Effects of diazepam on diploid Chinese hamster cells. Mutat. Res. 122:1983;201-209.
18. Liang J.C., Satya-Prakash K.L. Induction of aneuploidy by mitotic arrestants in mouse bone marrow. Mutat. Res. 155:1985;61-70.
19. Jordan M.A., Thrower D., Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res. 51:1991;2212-2222.
20. Seelbach A., Fissler B., Madle S. Further evaluation of a modified micronucleus assay with V79 cells for detection of aneugenic effects. Mutat. Res. 303:1993;163-169.
21. González Cid M., Mudry M., Larripa I. Chromosome damage induced by carboplatin (CBDCA). Toxicol. Lett. 76:1995;97-103.
22. Larramendy M.L., Knuutila S. Increased frequency of micronuclei in B and T lymphocytes from smokers. Mutat. Res. 259:1991;189-195.
23. Stern M., González Cid M., Larripa I., Slavutsky I. AZT-induction of micronuclei in human lymphocyte subpopulations. Toxicol. Lett. 70:1994;235-242.
24. Slavutsky I., Campos E., González Cid M., Larripa I. Micronuclei induction by carboplatin in human lymphocyte subpopulations. Anti-Cancer Drugs. 6:1995;758-762.
25. Holmén A., Karlsson A., Bratt I., Högstedt B. Micronuclei and mitotic index in B-, T4- and T8-cells treated with mitomycin C and γ-irradiation. Mutat. Res. 309:1994;93-99.